The activity reflects routine equity compensation and minor insider selling, not a signal of material concern. Monitor for follow-up selling or broader insider participation.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $18.89entry
- T+1 · 9mo ago +1.11%α +0.38% · $19.10
- T+5 · 9mo ago +22.50%α +21.88% · $23.14
- T+20 · 8mo ago +1.32%α +5.27% · $19.14
- T+60 · 6mo ago +13.55%α +5.30% · $21.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A recent insider trading cluster at 10x Genomics includes a non-cash share award to CFO Taich Adam and an open-market sale of $147K worth of shares by Sarah A. Teichmann. The sale represents minimal economic impact relative to the company's $2.9B market cap.
Key Financial Metrics
Key Facts
- CFO Taich Adam was awarded 106,579 shares at $0 (non-cash grant), typical of equity compensation.
- Sarah A. Teichmann sold 7,579 shares in the open market for $147,108.39 at $19.41 per share.
- The total open-market sale value ($147K) represents just 0.005% of the company's $2.9B market cap.
- No other open-market purchases or significant transactions occurred in the 7-day window.
Financial Impact
$147,108 in open-market selling, 0.005% of market cap
Risk Factors
- Single insider sale could indicate personal financial planning rather than fundamental concerns.
- Lack of insider buying may suggest limited near-term conviction.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-TXG-1772486628625 |
Track record
28 reports on TXG
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers